Votoplam (blinded) for huntington disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 8 Jan 2026: Trial registered, NCT07326709
  2. 24 Mar 2026: Trial started, NCT07326709

The trials

NCT07326709: A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease

State
Under way
Phase
Phase 3
People
770 planned
Started
24 Mar 2026
Primary completion
2 Apr 2030
Arms
Votoplam
Results
None posted
  1. 8 Jan 2026: Trial registered
  2. 24 Mar 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.